About 200 reports

Antibody to Inhibit TRAIL f or Pulmonary Arterial Hypertension

  • Hypertension
  • World
  • United States
  • North America
  • Drug Approval
  • Pharmaceutical Registrations

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Hypertension
  • Cardiovascular Drug
  • Calcium Channel Blocker
  • China
  • Industrial Production
  • Labour Force

Pulmonary Arterial Hypertension

  • Hypertension
  • South Africa
  • Drug Approval
  • Cause-Specific Mortality Rate

Abstract: - Global Pulmonary Hypertension Market to Reach $4.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Pulmonary Hypertension estimated at US$3.5 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 2.8% over the analysis period 2020-2027....

  • Hypertension
  • World
  • China
  • United States

Hypertension - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Pipeline Review, H1 2020, provides an overview of the Hypertension (Cardiovascular) pipeline landscape. Hypertension, also referred to as high blood pressure,...

  • Hypertension
  • Cardiology
  • World

“Pulmonary Arterial Hypertension (PAH) – Pipeline Insight, 2020,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Pulmonary Arterial Hypertension pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product...

  • Hypertension
  • Therapy
  • World
  • United States

Pulmonary Arterial Hypertension:

  • Hypertension
  • World
  • Mortality Rate
  • Sex Ratio

‘Pulmonary Arterial Hypertension - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pulmonary Arterial Hypertension in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan. Geography Covered • The United...

  • Hypertension
  • Epidemiology
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

Pulmonary Arterial Hypertension Market Report Overview Pulmonary Arterial Hypertension market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pulmonary Arterial Hypertension market types and applications. It is a focused study on Pulmonary...

  • Hypertension
  • World
  • Health Provider Density

Hypertension - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Pipeline Review, H2 2019, provides an overview of the Hypertension (Cardiovascular) pipeline landscape. Hypertension, also referred to as high blood pressure,...

  • Hypertension
  • Cardiology
  • World

The global pulmonary arterial hypertension (PAH) drugs market grew at a CAGR of around 6% during 2014-2019. Pulmonary arterial hypertension (PAH) refers to a life-threatening medical condition characterized by high blood pressure in the arteries that connect the heart to the lungs. It causes the artery walls to tighten...

  • Hypertension
  • World
  • Medical Technology Density

Pulmonary Arterial Hypertension Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Pulmonary Arterial Hypertension market including the COVID-19...

  • Hypertension
  • APAC
  • Central America

Top Companies Participating in Chronic Thromboembolic Pulmonary Hypertension Therapeutics Clinical Trials

  • Hypertension
  • G7
  • APAC
  • Diagnostic Imaging Density

Pulmonary Arterial Hypertension Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Pulmonary Arterial Hypertension Market Size, Outlook and Growth Opportunities to 2025: By Drug Class( Prostacyclin and Prostacyclin Analogs, Soluble Guanylate Cyclase (Sgc) Stimulators, Endothelin Receptor Antagonists, Phosphodiesterase,...

  • Hypertension
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pulmonary Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Hypertension
  • Cardiology
  • Therapy
  • Research And Development
  • World

Resistant Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Resistant Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Resistant Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Hypertension
  • Cardiology
  • Therapy
  • Research And Development
  • World

Idiopathic (Essential) Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Idiopathic (Essential) Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape. The report provides comprehensive...

  • Hypertension
  • Cardiology
  • Therapy
  • Research And Development
  • World

Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Chronic Thromboembolic Pulmonary Hypertension pipeline landscape. The...

  • Hypertension
  • Cardiology
  • Therapy
  • Research And Development
  • World

The ongoing clinical trial research report- “2019 Diabetic Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Diabetic Hypertension trials across the world. The report presents top level analysis of global Diabetic Hypertension clinical trials across countries, companies and universities. It is designed...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Idiopathic Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Idiopathic Hypertension trials across the world. The report presents top level analysis of global Idiopathic Hypertension clinical trials across countries, companies and universities. It is designed...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Intracranial Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Intracranial Hypertension trials across the world. The report presents top level analysis of global Intracranial Hypertension clinical trials across countries, companies and universities. It...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Portal Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Portal Hypertension trials across the world. The report presents top level analysis of global Portal Hypertension clinical trials across countries, companies and universities. It is designed to provide...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Pulmonary Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Pulmonary Hypertension trials across the world. The report presents top level analysis of global Pulmonary Hypertension clinical trials across countries, companies and universities. It is designed...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Resistant Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Resistant Hypertension trials across the world. The report presents top level analysis of global Resistant Hypertension clinical trials across countries, companies and universities. It is designed...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Systolic Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Systolic Hypertension trials across the world. The report presents top level analysis of global Systolic Hypertension clinical trials across countries, companies and universities. It is designed...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Essential Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Essential Hypertension trials across the world. The report presents top level analysis of global Essential Hypertension clinical trials across countries, companies and universities. It is designed...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Idiopathic Pulmonary Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Idiopathic Pulmonary Hypertension trials across the world. The report presents top level analysis of global Idiopathic Pulmonary Hypertension clinical trials across countries, companies...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Pulmonary Arterial Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Pulmonary Arterial Hypertension trials across the world. The report presents top level analysis of global Pulmonary Arterial Hypertension clinical trials across countries, companies and...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

The ongoing clinical trial research report- “2019 Chronic Thromboembolic Pulmonary Hypertension Ongoing Clinical Trials Study” analyzes the current scenario of all active Chronic Thromboembolic Pulmonary Hypertension trials across the world. The report presents top level analysis of global Chronic Thromboembolic Pulmonary Hypertension clinical...

  • Clinical Trial
  • Hypertension
  • World
  • APAC

‘Pulmonary Arterial Hypertension (PAH)- Market Insights, Epidemiology and Market Forecast-2030 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of PAH’s in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan. The Report provides the...

  • Hypertension
  • Therapy
  • Japan
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom